These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 9480459)
41. Class III drugs: their effects on arrhythmias and on the QT interval. Campbell R; Loaiza A Ann N Y Acad Sci; 1992 Jan; 644():223-34. PubMed ID: 1562116 [No Abstract] [Full Text] [Related]
42. Postrepolarization refractoriness: a mechanism in need for a molecule? Kirchhof P; Fabritz L Heart Rhythm; 2012 Jun; 9(6):983-4. PubMed ID: 22334152 [No Abstract] [Full Text] [Related]
43. Population pharmacokinetic and pharmacodynamic analysis of a class IC antiarrhythmic, pilsicainide, in patients with cardiac arrhythmias. Ogawa R; Kishi R; Mihara K; Takahashi H; Takagi A; Matsumoto N; Masuhara K; Nakazawa K; Miyake F; Kobayashi S; Echizen H J Clin Pharmacol; 2006 Jan; 46(1):59-68. PubMed ID: 16397285 [TBL] [Abstract][Full Text] [Related]
44. [Electrophysiologic effects of bepridil on the human heart]. Valère PE; Belin A; Chentir T; Lehner JP; Guerot C; Tricot R Ann Cardiol Angeiol (Paris); 1982; 31(5):409-15. PubMed ID: 6984315 [No Abstract] [Full Text] [Related]
46. Antiarrhythmic drugs and ion channels: have we made the connection? Carmeliet E J Cardiovasc Electrophysiol; 1999 May; 10(5):755-9. PubMed ID: 10355931 [No Abstract] [Full Text] [Related]
47. Clinical application of new concepts of parasystole, reflection, and tachycardia. Antzelevitch C Cardiol Clin; 1983 Feb; 1(1):39-50. PubMed ID: 6399992 [TBL] [Abstract][Full Text] [Related]
48. Effect of antiarrhythmic drugs on the A-V conduction in isolated hearts. Brusca A; Rosettani E; Favella L G Ital Cardiol; 1972; 2(1):158. PubMed ID: 5011998 [No Abstract] [Full Text] [Related]
49. Classification and pharmacology of antiarrhythmic drugs. Kowey PR; Marinchak RA; Rials SJ; Bharucha DB Am Heart J; 2000 Jul; 140(1):12-20. PubMed ID: 10874257 [TBL] [Abstract][Full Text] [Related]
50. [Proarrhythmic effects of anti-arrhythmia agents]. Enrico JF; Kehtari R Rev Med Suisse Romande; 1998 Aug; 118(8):671-90. PubMed ID: 9838826 [No Abstract] [Full Text] [Related]
51. [Pharmacological study of (naphtyloxy-1)4-hydroxy-3 butyramidoxime chlorhydrate or LL 1530. Anti-arrhythmic action]. Duteil J; Nadaud J; Henry M; Assous E; Gombert R Therapie; 1973; 28(4):703-20. PubMed ID: 4793689 [No Abstract] [Full Text] [Related]
53. Ischemic modulation of vulnerable period and the effects of pharmacological treatment of ischemia-induced arrhythmias: a simulation study. Cimponeriu A; Starmer CF; Bezerianos A IEEE Trans Biomed Eng; 2003 Feb; 50(2):168-77. PubMed ID: 12665030 [TBL] [Abstract][Full Text] [Related]
54. Differential responsiveness to antiarrhythmic drugs in the rabbit atrio-ventricular conducting system. Németh M; Papp JG; Szekeres L Acta Physiol Hung; 1990; 75 Suppl():223-4. PubMed ID: 2371871 [No Abstract] [Full Text] [Related]
55. Pharmacologic basis for the clinical use of antiarrhythmic drugs. Morrelli HF; Melmon KL Pharmacol Physicians; 1967 Jul; 1(7):1-8. PubMed ID: 6047103 [No Abstract] [Full Text] [Related]
56. Newer antiarrhythmic drugs. An electrophysiologic appreciation. Nair KG; Sharma S Indian Heart J Teach Ser; 1980; (7):347-58. PubMed ID: 7309056 [No Abstract] [Full Text] [Related]